FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Amoeba Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Keep out of reach of children. In case of overdose, contact a physician or a Poison Control Center right away.
If pregnant or breast-feeding, ask a health professional before use.
Tamper seal: "Sealed for your protection." Do not use if seal is broken or missing.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
For temporary relief of symptoms related to amoeba infestation including chronic dysentery and consequent weakness and dehydration, bloody stools, jaundice, fever, weight loss, and stomach cramps.
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Amoeba Manufacturers
- Deseret Biologicals, Inc.
- Deseret Biologicals, Inc.
Amoeba | Blenheim Pharmacal, Inc.
Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day.
0.4 mg once daily taken approximately one-half hour following the same meal each day (2) Can be increased to 0.8 mg once daily for patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing (2) If discontinued or interrupted for several days, therapy should start again with the 0.4 mg once-daily dose (2)
For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see Warnings and Precautions (5.2)].
If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. - Deseret Biologicals, Inc.
Login To Your Free Account